約50名會員公司代表，於2019年3月27日出席了香港科研製藥聯會的周年會員大會。(請參閱英文版本)

Riding on the solid partnership with stakeholders, 2018 has been a fruitful year for HKAPI. Our President Caroline Johnson addressed in the AGM that HKAPI had accelerated the momentum and drive policy changes. The HKAPI will continue to enhance interactions and facilitate more communications among our members and stakeholders this year.

Our different task forces including Patients, Enlistment & Risk Sharing, Preventive & Primary Healthcare, Open Access, Regulatory Affairs, Macao, R&D Ecosystem, Ethics & Compliance, Communications Committee, as well as the new task force namely HA Efficiency Transformation to be set up this year, will work together to achieve our constant pursuit of the holistic approach of the people-centered care.